Your session is about to expire
← Back to Search
Topical TDM-105795 for Male Pattern Baldness
Study Summary
This trial tested a drug for male hair loss using a blind, scientific study with multiple doses.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have mild to moderate hair loss on the top and sides of my head.I haven't used any hair growth products like Aminexil or Nioxin in the last 4 weeks.I have experienced hair loss due to conditions other than male/female pattern baldness.I have received radiation treatment on my scalp.I have used hair loss treatments like finasteride or minoxidil in the last 6 months.My kidney, liver, and thyroid functions are normal according to my recent tests.I have cancer, but it's not skin cancer in the area being treated.I haven't taken isotretinoin, high-dose vitamin A, or cyclosporine in the last 6 months.I have not had any scalp treatments in the last 6 months.I haven't used any experimental treatments in the last 30 days or 5 half-lives.I am able to follow the study's requirements.I have used chemotherapy or similar treatments within the last year.I haven't used any treatments that could affect my hair growth, including vitamins or steroids.I am a man aged between 18 and 55.I do not have any skin conditions on my scalp that could affect the study.I have had PRP treatments on my scalp.I have been treated with the investigational product before.You have had significant changes in your diet or weight, or a history of eating disorders that have caused hair loss within the past 6 months.I haven't used any hair growth treatments on my scalp in the last 12 weeks.I have symptoms of COVID-19 or was diagnosed with it in the last 4 weeks.You have a skin condition or thyroid disease that could affect the study, or you need to use treatments that could interfere with the study.I agree to not change my hair style, length, or color during the study.You have tested positive for HIV, hepatitis B, or hepatitis C in a blood test.You tested positive for alcohol or drugs during the initial screening or baseline visit.I agree to not change my hair care routine for 2 weeks before my next visit and during the study.You have not used any tobacco or nicotine products for more than 4 months before the start of the study.I am willing and able to follow the study's treatment plan and attend all appointments.I do not have skin conditions on my scalp that could affect treatment application or assessment.I have had scalp surgery, significant head injury, hair transplants, or weaves.I haven't used any scalp treatments affecting hair growth in the last 4 weeks.I haven't taken certain medications like beta blockers or steroids in the last 12 weeks.
- Group 1: TDM-105795 topical solution, 0.0025%
- Group 2: TDM-105795 topical solution, 0.02%
- Group 3: TDM-105795 topical vehicle solution
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What implications will there be for patients that use TDM-105795 topical solution, 0.0025%?
"Considering its Phase 2 status, there is some evidence of TDM-105795 topical solution 0.0025%'s safety but no data to support the efficacy; thus it has been allocated a score of 2."
Is eligibility limited to individuals aged 75 or younger for this experiment?
"To be eligible for this medical study, patients must fit the age bracket of 18 to 55. 12 trials that are suitable for people younger than 18 and 59 studies fitting those over 65 years old are also available."
What are the eligibility criteria for participation in this investigation?
"To partake in this medical trial, candidates must have male pattern baldness and be between 18-55 years old. A maximum of 72 participants will be enrolled in the study."
Are enrollment opportunities still available for this research project?
"Accurate. According to clinicaltrials.gov, recruitment for this particular trial is not open at the moment since it was last updated on March 26th 2023. However, there are 83 other experiments that are currently recruiting individuals for study participation."
What goals is this research endeavor striving to achieve?
"Per the clinical trial sponsor, Technoderma Medicines Inc., the primary purpose of this 16-week experiment is to observe treatment efficacy. Secondary goals include assessing non-vellus target area hair darkness (TAHD) at week 16 and evaluating patient satisfaction with their results through a Hair Growth Index (HGI) questionnaire. Scalp hair growth will be measured via Canfield Review application using a 7 point scale ranging from much less (-3), moderately less (-2), slightly less (-1), same amount (0), slightly more (1), moderately more (2) to much more(3). Similarly, investigators' global assessment grade's"
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What state do they live in?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- Site 6: < 24 hours
- Virginia Clinical Research, Inc.: < 24 hours
Typically responds via
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger